A clinical trial to to study the effect of Kanchanara Gutika in patients with Hypothyroidism

A randomised controlled trial of Kanchanara Gutika in the management of Primary Hypothyroidism - RAKH

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020464

Enrollment

Registered

2019-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E039- Hypothyroidism, unspecified

Interventions

Intervention1: Kanchanara Gutika Thyroxin: Kanchanara Gutika 1gr thrice orally for 3 months Thyroxine given orally for 3 months

Eligibility

Inclusion criteria

Inclusion criteria: patients with primary hypothryroidism

Exclusion criteria

Exclusion criteria: Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc. Patients suffering from congenital hypothyroidism and secondary hypothyroidism. Pregnant women, patients with hyperthyroidism will be excluded.

Design outcomes

Primary

Measure	Time frame
Thryroid ProfileTimepoint: 3 months	—

Secondary

Measure	Time frame
Zulewskis scaleTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr S Gnana Prasuna

Parul Institute of Ayurveda

manu.r260022@paruluniversity.ac.in9989480297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026